{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:36:29Z","timestamp":1790958989005,"version":"4.1.0"},"reference-count":231,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The rapid progress of antibiotic resistance among bacteria has prompted serious medical concerns regarding how to manage multidrug-resistant (MDR) bacterial infections. One emerging strategy to combat antibiotic resistance is the use of antimicrobial peptides (AMPs), which are amino acid chains that act as broad-spectrum antimicrobial molecules and are essential parts of the innate immune system in mammals, fungi, and plants. AMPs have unique antibacterial mechanisms that offer benefits over conventional antibiotics in combating drug-resistant bacterial infections. Currently, scientists have conducted multiple studies on AMPs for combating drug-resistant bacterial infections and found that AMPs are a promising alternative to conventional antibiotics. On the other hand, bacteria can develop several tactics to resist and bypass the effect of AMPs. Therefore, it is like a battle between the bacterial community and the AMPs, but who will win? This review provides thorough insights into the development of antibiotic resistance as well as detailed information about AMPs in terms of their history and classification. Furthermore, it addresses the unique antibacterial mechanisms of action of AMPs, how bacteria resist these mechanisms, and how to ensure AMPs win this battle. Finally, it provides updated information about FDA-approved AMPs and those that were still in clinical trials. This review provides vital information for researchers for the development and therapeutic application of novel AMPs for drug-resistant bacterial infections.<\/jats:p>","DOI":"10.3390\/ph17111555","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:02:58Z","timestamp":1732086178000},"page":"1555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Antimicrobial Peptides: The Game-Changer in the Epic Battle Against Multidrug-Resistant Bacteria"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"first","affiliation":[{"name":"Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-6332","authenticated-orcid":false,"given":"Nizar","family":"Sirag","sequence":"additional","affiliation":[{"name":"Division of Pharmacognosy, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0284-8208","authenticated-orcid":false,"given":"Shumukh M.","family":"Alsharif","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1100-4771","authenticated-orcid":false,"given":"Ahmad A.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala T.","family":"Alkindy","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0627-9003","authenticated-orcid":false,"given":"Alanoud","family":"Alkhamali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8967-9875","authenticated-orcid":false,"given":"Abdullah S.","family":"Albalawi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7374-9334","authenticated-orcid":false,"given":"Yasmin N.","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab I.","family":"Rashed","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz E.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"ref_1","unstructured":"CDC (2024, March 01). Antimicrobial (AR) Threats Report, Available online: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_3","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Algammal, A., Hetta, H.F., Mabrok, M., and Behzadi, P. (2023). Emerging multidrug-resistant bacterial pathogens \u201csuperbugs\u201d: A rising public health threat. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1135614"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Rashed, Z.I., Ramadan, Y.N., Al-Kadmy, I.M.S., Kassem, S.M., Ata, H.S., and Nageeb, W.M. (2023). Phage Therapy, a Salvage Treatment for Multidrug-Resistant Bacteria Causing Infective Endocarditis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102860"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Ramadan, Y.N., Rashed, Z.I., Alharbi, A.A., Alsharef, S., Alkindy, T.T., Alkhamali, A., Albalawi, A.S., Battah, B., and Donadu, M.G. (2024). Quorum Sensing Inhibitors: An Alternative Strategy to Win the Battle against Multidrug-Resistant (MDR) Bacteria. Molecules, 29.","DOI":"10.3390\/molecules29153466"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Ramadan, Y.N., Al-Kadmy, I.M.S., Ellah, N.H.A., Shbibe, L., and Battah, B. (2023). Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections. Pathogens, 12.","DOI":"10.3390\/pathogens12081033"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13238-010-0004-3","article-title":"Alpha-helical cationic antimicrobial peptides: Relationships of structure and function","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: Form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/s11535-007-0010-5","article-title":"Antimicrobial peptides: An overview of a promising class of therapeutics","volume":"2","author":"Giuliani","year":"2007","journal-title":"Open Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mahlapuu, M., H\u00e5kansson, J., Ringstad, L., and Bj\u00f6rn, C. (2016). Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front. Cell. Infect. Microbiol., 6.","DOI":"10.3389\/fcimb.2016.00194"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hansen, I., L\u00f6vdahl, T., Simonovic, D., Hansen, K., Andersen, A.J.C., Devold, H., Richard, C.S.M., Andersen, J.H., Str\u00f8m, M.B., and Haug, T. (2020). Antimicrobial Activity of Small Synthetic Peptides Based on the Marine Peptide Turgencin A: Prediction of Antimicrobial Peptide Sequences in a Natural Peptide and Strategy for Optimization of Potency. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155460"},{"key":"ref_14","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gagat, P., Ostr\u00f3wka, M., Duda-Madej, A., and Mackiewicz, P. (2024). Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910821"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100954","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Taheri-Araghi, S. (2024). Synergistic action of antimicrobial peptides and antibiotics: Current understanding and future directions. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1390765"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dijksteel, G.S., Ulrich, M.M.W., Middelkoop, E., and Boekema, B.K.H.L. (2021). Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs). Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.616979"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111814","DOI":"10.1016\/j.ejmech.2019.111814","article-title":"Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa","volume":"185","author":"Kim","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/psc.2633","article-title":"Self-assembling amphiphilic peptides","volume":"20","author":"Dehsorkhi","year":"2014","journal-title":"J. Pept. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12774","DOI":"10.1021\/ja0270423","article-title":"Structure-activity studies of 14-helical antimicrobial beta-peptides: Probing the relationship between conformational stability and antimicrobial potency","volume":"124","author":"Raguse","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.mpmed.2017.07.006","article-title":"Antibiotic resistance","volume":"45","author":"MacGowan","year":"2017","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/IDR.S151783","article-title":"Ambulance vehicles as a source of multidrug-resistant infections: A multicenter study in Assiut City, Egypt","volume":"11","author":"Hetta","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"VMBF-0016-2015","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Ramadan, Y.N., Al-Harbi AI, A., Ahmed, E., Battah, B., Abd Ellah, N.H., Zanetti, S., and Donadu, M.G. (2023). Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020413"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/IDR.S238811","article-title":"Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa","volume":"13","author":"Masoud","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/IDR.S275852","article-title":"Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Klebsiella pneumoniae","volume":"14","author":"Kareem","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1365-2958.2009.06596.x","article-title":"Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket","volume":"71","author":"Long","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/AAC.00164-13","article-title":"Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible","volume":"57","author":"Takaya","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/IDR.S272733","article-title":"Methicillin-Resistant Staphylococcus aureus (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact","volume":"13","author":"Algammal","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"015004","DOI":"10.1088\/2399-1984\/aa69fb","article-title":"Synergistic antimicrobial therapy using nanoparticles and antibiotics for the treatment of multidrug-resistant bacterial infection","volume":"1","author":"Gupta","year":"2017","journal-title":"Nano Futures"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106184","DOI":"10.1016\/j.micpath.2023.106184","article-title":"Anti-capsular activity of CuO nanoparticles against Acinetobacter baumannii produce efflux pump","volume":"181","author":"Aziz","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"El-Kazzaz, W., Metwally, L., Yahia, R., Al-Harbi, N., El-Taher, A., and Hetta, H.F. (2020). Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090603"},{"key":"ref_36","first-page":"4","article-title":"Antimicrobial resistance pattern and molecular epidemiology of ESBL and MBL producing Acinetobacter baumannii isolated from hospitals in Minia, Egypt","volume":"56","author":"Farhan","year":"2020","journal-title":"Alex. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/IDR.S198373","article-title":"Antimicrobial resistance pattern and molecular genetic distribution of metallo-\u03b2-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt","volume":"12","author":"Farhan","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.2147\/IDR.S276975","article-title":"Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections","volume":"13","author":"Makharita","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2147\/IDR.S201124","article-title":"A novel mechanism of action of ketoconazole: Inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus","volume":"12","author":"Sandle","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: Structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophys. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nageeb, W.M., AlHarbi, N., Alrehaili, A.A., Zakai, S.A., Elfadadny, A., and Hetta, H.F. (2023). Global genomic epidemiology of chromosomally mediated non-enzymatic carbapenem resistance in Acinetobacter baumannii: On the way to predict and modify resistance. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1271733"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nageeb, W.M., and Hetta, H.F. (2022). The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0267396"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Nageeb, W.M., and Hetta, H.F. (2023). Pangenome analysis of Corynebacterium striatum: Insights into a neglected multidrug-resistant pathogen. BMC Microbiol., 23.","DOI":"10.1186\/s12866-023-02996-6"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2147\/IDR.S377797","article-title":"Sequence Analysis, Antibiogram Profile, Virulence and Antibiotic Resistance Genes of XDR and MDR Gallibacterium anatis Isolated from Layer Chickens in Egypt","volume":"15","author":"Algammal","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/IDR.S365254","article-title":"Newly Emerging MDR B. cereus in Mugil seheli as the First Report Commonly Harbor nhe, hbl, cytK, and pc-plc Virulence Genes and bla1, bla2, tetA, and ermA Resistance Genes","volume":"15","author":"Algammal","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Algammal, A.M., Eid, H.M., Alghamdi, S., Ghabban, H., Alatawy, R., Almanzalawi, E.A., Alqahtani, T.M., Elfouly, S.G., Mohammed, G.M., and Hetta, H.F. (2024). Meat and meat products as potential sources of emerging MDR Bacillus cereus: GroEL gene sequencing, toxigenic and antimicrobial resistance. BMC Microbiol., 24.","DOI":"10.1186\/s12866-024-03204-9"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2147\/IDR.S401473","article-title":"oprL Gene Sequencing, Resistance Patterns, Virulence Genes, Quorum Sensing and Antibiotic Resistance Genes of XDR Pseudomonas aeruginosa Isolated from Broiler Chickens","volume":"16","author":"Algammal","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13568-023-01615-x","article-title":"Resistance profiles, virulence and antimicrobial resistance genes of XDR S. Enteritidis and S. Typhimurium","volume":"13","author":"Algammal","year":"2023","journal-title":"AMB Express"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Algammal, A.M., Hashem, H.R., Al-Otaibi, A.S., Alfifi, K.J., El-Dawody, E.M., Mahrous, E., Hetta, H.F., El-Kholy, A.W., Ramadan, H., and El-Tarabili, R.M. (2021). Emerging MDR-Mycobacterium avium subsp. avium in house-reared domestic birds as the first report in Egypt. BMC Microbiol., 21.","DOI":"10.1186\/s12866-021-02287-y"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Algammal, A.M., Hashem, H.R., Alfifi, K.J., Hetta, H.F., Sheraba, N.S., Ramadan, H., and El-Tarabili, R.M. (2021). atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88861-w"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Algammal, A.M., Hetta, H.F., Batiha, G.E., Hozzein, W.N., El Kazzaz, W.M., Hashem, H.R., Tawfik, A.M., and El-Tarabili, R.M. (2020). Virulence-determinants and antibiotic-resistance genes of MDR-E. coli isolated from secondary infections following FMD-outbreak in cattle. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-75914-9"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Algammal, A.M., Mabrok, M., Sivaramasamy, E., Youssef, F.M., Atwa, M.H., El-Kholy, A.W., Hetta, H.F., and Hozzein, W.N. (2020). Emerging MDR-Pseudomonas aeruginosa in fish commonly harbor oprL and toxA virulence genes and blaTEM, blaCTX-M, and tetA antibiotic-resistance genes. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-72264-4"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects P seudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijbiomac.2022.05.156","article-title":"Smart active-targeting of lipid-polymer hybrid nanoparticles for therapeutic applications: Recent advances and challenges","volume":"213","author":"Khalili","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Khalil, M.A.F., Ahmed, F.A., Elkhateeb, A.F., Mahmoud, E.E., Ahmed, M.I., Ahmed, R.I., Hosni, A., Alghamdi, S., Kabrah, A., and Dablool, A.S. (2021). Virulence Characteristics of Biofilm-Forming Acinetobacter baumannii in Clinical Isolates Using a Galleria mellonella Model. Microorganisms, 9.","DOI":"10.3390\/microorganisms9112365"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1007\/s11033-023-08447-9","article-title":"Binary CuO\\CoO nanoparticles inhibit biofilm formation and reduce the expression of papC and fimH genes in multidrug-resistant Klebsiella oxytoca","volume":"50","author":"Aziz","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Hetta, H.F., Al-Kadmy, I., Khazaal, S.S., Abbas, S., Suhail, A., El-Mokhtar, M.A., Ellah, N.H.A., Ahmed, E.A., Abd-Ellatief, R.B., and El-Masry, E.A. (2021). Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-90208-4"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1556\/1886.2024.00014","article-title":"Characterization of antibiotic and disinfectant susceptibility in biofilm-forming Acinetobacter baumannii: A focus on environmental isolates","volume":"14","author":"Szabados","year":"2024","journal-title":"Eur. J. Microbiol. Immunol. (Bp)"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Salah, M., Badr, G., Hetta, H.F., Khalifa, W.A., and Shoreit, A.A. (2022). Fig latex inhibits the growth of pathogenic bacteria invading human diabetic wounds and accelerates wound closure in diabetic mice. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-26338-0"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","article-title":"Antimicrobial peptides","volume":"26","author":"Zhang","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkh025","article-title":"APD: The antimicrobial peptide database","volume":"32","author":"Wang","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bucataru, C., and Ciobanasu, C. (2024). Antimicrobial peptides: Opportunities and challenges in overcoming resistance. Microbiol. Res., 286.","DOI":"10.1016\/j.micres.2024.127822"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Huan, Y., Kong, Q., Mou, H., and Yi, H. (2020). Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.582779"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijantimicag.2004.09.005","article-title":"Antimicrobial peptides: Premises and promises","volume":"24","author":"Reddy","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2014.165","article-title":"Fetal human keratinocytes produce large amounts of antimicrobial peptides: Involvement of histone-methylation processes","volume":"134","author":"Gschwandtner","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jn\/135.1.1","article-title":"The immunological components of human milk and their effect on immune development in infants","volume":"135","author":"Field","year":"2005","journal-title":"J. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbrc.2017.02.108","article-title":"Antimicrobial activity and mechanism of the human milk-sourced peptide Casein201","volume":"485","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tifs.2014.01.002","article-title":"Dairy-derived antimicrobial peptides: Action mechanisms, pharmaceutical uses and production proposals","volume":"36","year":"2014","journal-title":"Trends Food Sci. Technol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang","year":"2014","journal-title":"Pharmaceuticals"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.bbamem.2009.03.008","article-title":"The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines","volume":"1788","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ph7010058","article-title":"Host-defense peptides with therapeutic potential from skin secretions of frogs from the family Pipidae","volume":"7","author":"Conlon","year":"2014","journal-title":"Pharmaceuticals"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.molimm.2007.07.004","article-title":"The first antimicrobial peptide from sea amphibian","volume":"45","author":"Lu","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jinsphys.2012.08.018","article-title":"Evolutionary plasticity of insect immunity","volume":"59","author":"Vilcinskas","year":"2013","journal-title":"J. Insect Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Dutta, P., Sahu, R.K., Dey, T., Lahkar, M.D., Manna, P., and Kalita, J. (2019). Beneficial role of insect-derived bioactive components against inflammation and its associated complications (colitis and arthritis) and cancer. Chem.-Biol. Interact., 313.","DOI":"10.1016\/j.cbi.2019.108824"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"107823","DOI":"10.1016\/j.exppara.2019.107823","article-title":"Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite","volume":"209","author":"Zahedifard","year":"2020","journal-title":"Exp. Parasitol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acssynbio.7b00396","article-title":"Yeast-Based Synthetic Biology Platform for Antimicrobial Peptide Production","volume":"7","author":"Cao","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2007.00683.x","article-title":"Antimicrobial peptides and plant disease control","volume":"270","author":"Montesinos","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10989-020-10110-x","article-title":"Antimicrobial Peptides as Potential Therapeutic Agents: A Review","volume":"27","author":"Datta","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Salas, C.E., Badillo-Corona, J.A., Ram\u00edrez-Sotelo, G., and Oliver-Salvador, C. (2015). Biologically Active and Antimicrobial Peptides from Plants. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/102129"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Baindara, P., and Mandal, S.M. (2022). Plant-Derived Antimicrobial Peptides: Novel Preservatives for the Food Industry. Foods, 11.","DOI":"10.3390\/foods11162415"},{"key":"ref_83","unstructured":"Wang, G. (2017). Discovery, classification and functional diversity of antimicrobial peptides. Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, CABI."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.3390\/molecules20046941","article-title":"NKCS, a mutant of the NK-2 peptide, causes severe distortions and perforations in bacterial, but not human model lipid membranes","volume":"20","author":"Ciobanasu","year":"2015","journal-title":"Molecules"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sancho-Vaello, E., Gil-Carton, D., Fran\u00e7ois, P., Bonetti, E.-J., Kreir, M., Pothula, K.R., Kleinekath\u00f6fer, U., and Zeth, K. (2020). The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-74401-5"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tips.2019.04.012","article-title":"The vast structural diversity of antimicrobial peptides","volume":"40","author":"Koehbach","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/1389203719666180226155035","article-title":"An Atlas of Anionic Antimicrobial Peptides from Amphibians","volume":"19","author":"Dennison","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1021\/acs.langmuir.0c02306","article-title":"Interactions of an Anionic Antimicrobial Peptide with Zinc(II): Application to Bacterial Mimetic Membranes","volume":"36","author":"Almarwani","year":"2020","journal-title":"Langmuir"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-2836(75)90225-9","article-title":"The phylogeny of trypsin-related serine proteases and their zymogens. New methods for the investigation of distant evolutionary relationships","volume":"92","author":"Neurath","year":"1975","journal-title":"J. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Miller, A., Matera-Witkiewicz, A., Miko\u0142ajczyk, A., W\u0105t\u0142y, J., Wilcox, D., Witkowska, D., and Rowi\u0144ska-\u017byrek, M. (2021). Zn-Enhanced Asp-Rich Antimicrobial Peptides: N-Terminal Coordination by Zn(II) and Cu(II), Which Distinguishes Cu(II) Binding to Different Peptides. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136971"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plipres.2011.12.005","article-title":"Role of lipids in the interaction of antimicrobial peptides with membranes","volume":"51","author":"Teixeira","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9","article-title":"Structural features and biological activities of the cathelicidin-derived antimicrobial peptides","volume":"55","author":"Gennaro","year":"2000","journal-title":"Biopolymers"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.3390\/molecules200815392","article-title":"The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases","volume":"20","author":"Lewies","year":"2015","journal-title":"Molecules"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/eos.12664","article-title":"Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells of human whole saliva","volume":"128","author":"Aidoukovitch","year":"2020","journal-title":"Eur. J. Oral Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.pharep.2016.03.015","article-title":"LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity","volume":"68","author":"Fabisiak","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","article-title":"Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37","volume":"273","author":"Johansson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Angelini, P. (2024). Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance. Antibiotics, 13.","DOI":"10.3390\/antibiotics13080746"},{"key":"ref_99","unstructured":"Zhao, H. (2003). Mode of Action of Antimicrobial Peptides, Helsingin Yliopisto."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-065X.2011.01082.x","article-title":"\u03b1-Defensins in human innate immunity","volume":"245","author":"Lehrer","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/IAI.01414-13","article-title":"Hydrophobic determinants of \u03b1-defensin bactericidal activity","volume":"82","author":"Tai","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_102","first-page":"48","article-title":"Antimicrobial peptides: Mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Koehbach, J. (2017). Structure-Activity Relationships of Insect Defensins. Front. Chem., 5.","DOI":"10.3389\/fchem.2017.00045"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1073\/pnas.1912941117","article-title":"Structure, function, and evolution of Gga-AvBD11, the archetype of the structural avian-double-\u03b2-defensin family","volume":"117","author":"Guyot","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2174\/092986706776055689","article-title":"Antimicrobial peptides with unusual amino acid compositions and unusual structures","volume":"13","author":"Sitaram","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1389203043379459","article-title":"Theta-defensins: Cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins","volume":"5","author":"Selsted","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: The antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Decker, A.P., Mechesso, A.F., and Wang, G. (2022). Expanding the landscape of amino acid-rich antimicrobial peptides: Definition, deployment in nature, implications for peptide design and therapeutic potential. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112874"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wang, G. (2022). Unifying the classification of antimicrobial peptides in the antimicrobial peptide database. Methods in Enzymology, Elsevier.","DOI":"10.1016\/bs.mie.2021.09.006"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/cbic.201300778","article-title":"Baceridin, a cyclic hexapeptide from an epiphytic Bacillus strain, inhibits the proteasome","volume":"15","author":"Niggemann","year":"2014","journal-title":"ChemBioChem"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Graf, M., and Wilson, D.N. (2019). Intracellular antimicrobial peptides targeting the protein synthesis machinery. Antimicrobial Peptides, Springer.","DOI":"10.1007\/978-981-13-3588-4_6"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Aisenbrey, C., Marquette, A., and Bechinger, B. (2019). The mechanisms of action of cationic antimicrobial peptides refined by novel concepts from biophysical investigations. Antimicrobial Peptides, Springer.","DOI":"10.1007\/978-981-13-3588-4_4"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"100051","DOI":"10.1016\/j.microb.2024.100051","article-title":"Antimicrobial peptides as therapeutics: Confronting delivery challenges to optimize efficacy","volume":"2","author":"Asif","year":"2024","journal-title":"Microbe"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/bip.20970","article-title":"Synthetic mimics of antimicrobial peptides","volume":"90","author":"Som","year":"2008","journal-title":"Biopolymers"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","article-title":"The expanding scope of antimicrobial peptide structures and their modes of action","volume":"29","author":"Nguyen","year":"2011","journal-title":"Trends Biotechnol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","article-title":"Multifunctional cationic host defence peptides and their clinical applications","volume":"68","author":"Yeung","year":"2011","journal-title":"Cell Mol. Life Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1568026615666150703121518","article-title":"Interactions of Antimicrobial Peptides with Bacterial Membranes and Membrane Components","volume":"16","author":"Malmsten","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ebenhan, T., Gheysens, O., Kruger, H.G., Zeevaart, J.R., and Sathekge, M.M. (2014). Antimicrobial peptides: Their role as infection-selective tracers for molecular imaging. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/867381"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Kumar, P., Kizhakkedathu, J.N., and Straus, S.K. (2018). Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules, 8.","DOI":"10.3390\/biom8010004"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568026615666150703121700","article-title":"Antimicrobial peptide structure and mechanism of action: A focus on the role of membrane structure","volume":"16","author":"Lee","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Miao, H., Wang, L., Wu, Q., and Huang, Z. (2024). Antimicrobial peptides: Antimicrobial Peptides: Mechanism, Expressions, and Optimization Strategies. Probiotics Antimicrob. Proteins.","DOI":"10.1007\/s12602-024-10391-4"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanisms of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert. Rev. Anti-infect. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1568005024605855","article-title":"Clinical development of cationic antimicrobial peptides: From natural to novel antibiotics","volume":"2","author":"Hancock","year":"2002","journal-title":"Curr. Drug Targets-Infect. Disord."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1021\/acs.biochem.6b00101","article-title":"Low pH Enhances the Action of Maximin H5 against Staphylococcus aureus and Helps Mediate Lysylated Phosphatidylglycerol-Induced Resistance","volume":"55","author":"Dennison","year":"2016","journal-title":"Biochemistry"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00203-016-1206-8","article-title":"A novel short anionic antibacterial peptide isolated from the skin of Xenopus laevis with broad antibacterial activity and inhibitory activity against breast cancer cell","volume":"198","author":"Li","year":"2016","journal-title":"Arch. Microbiol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Cardoso, M.H., Meneguetti, B.T., Costa, B.O., Buccini, D.F., Oshiro, K.G.N., Preza, S.L.E., Carvalho, C.M.E., Migliolo, L., and Franco, O.L. (2019). Non-Lytic Antibacterial Peptides That Translocate Through Bacterial Membranes to Act on Intracellular Targets. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194877"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/psc.2990","article-title":"Novel short antimicrobial peptide isolated from Xenopus laevis skin","volume":"23","author":"Zhang","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/iai.61.7.2978-2984.1993","article-title":"Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine","volume":"61","author":"Boman","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1021\/acsabm.0c01485","article-title":"Release strategies of silver ions from materials for bacterial killing","volume":"4","author":"Xu","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nsmb.3031","article-title":"The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin","volume":"22","author":"Roy","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nsmb.3439","article-title":"An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome","volume":"24","author":"Florin","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1073\/pnas.1817352116","article-title":"Structural mechanism of transcription inhibition by lasso peptides microcin J25 and capistruin","volume":"116","author":"Braffman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.12659\/MSM.902095","article-title":"Escherichia coli PagP Enzyme-Based De Novo Design and In Vitro Activity of Antibacterial Peptide LL-37","volume":"23","author":"Yang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1007\/s00253-019-09981-y","article-title":"Mechanism of antimicrobial peptide NP-6 from Sichuan pepper seeds against E. coli and effects of different environmental factors on its activity","volume":"103","author":"Hou","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e00077-20","DOI":"10.1128\/msystems.00077-20","article-title":"The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: An Untargeted Metabolomics Study","volume":"5","author":"Hussein","year":"2020","journal-title":"mSystems"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.immuni.2015.07.013","article-title":"Pancreatic \u03b2-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota","volume":"43","author":"Sun","year":"2015","journal-title":"Immunity"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Luo, Y., and Song, Y. (2021). Mechanism of antimicrobial peptides: Antimicrobial, anti-inflammatory and antibiofilm activities. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111401"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1021\/acsabm.0c00849","article-title":"Single-Cell Tracking on Polymer Microarrays Reveals the Impact of Surface Chemistry on Pseudomonas aeruginosa Twitching Speed and Biofilm Development","volume":"3","author":"Carabelli","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbamem.2019.05.008","article-title":"Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa","volume":"1861","author":"Martinez","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/IAI.00318-08","article-title":"Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation","volume":"76","author":"Overhage","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Mohamed, M.F., Abdelkhalek, A., and Seleem, M.N. (2016). Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci. Rep., 6.","DOI":"10.1038\/srep29707"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Marks, L.R., Clementi, E.A., and Hakansson, A.P. (2012). The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043514"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1111\/j.1742-4658.2009.07257.x","article-title":"Esculentin-1b (1\u201318)\u2013a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli","volume":"276","author":"Marcellini","year":"2009","journal-title":"FEBS J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4014\/jmb.1807.07002","article-title":"Novel Approaches for Efficient Antifungal Drug Action","volume":"28","author":"Lee","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01180-12","article-title":"In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms","volume":"56","author":"Mataraci","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Li, S., She, P., Zhou, L., Zeng, X., Xu, L., Liu, Y., Chen, L., and Wu, Y. (2020). High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.591426"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1472-765X.2007.02157.x","article-title":"Epsilon-poly-L-lysine and nisin A act synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria monocytogenes","volume":"45","author":"Kashtanov","year":"2007","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(98)00351-9","article-title":"Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices","volume":"106","author":"Jacobs","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s12272-016-0769-x","article-title":"The antimicrobial activity of Cbf-K 16 against MRSA was enhanced by \u03b2-lactamantibiotics through cell wall non-integrity","volume":"39","author":"Li","year":"2016","journal-title":"Arch. Pharmacal Res."},{"key":"ref_154","first-page":"232","article-title":"Ib-AMP4 antimicrobial peptide as a treatment for skin and systematic infection of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"25","author":"Sadelaji","year":"2022","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"eaan4044","DOI":"10.1126\/scitranslmed.aan4044","article-title":"The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms","volume":"10","author":"Riool","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"43506","DOI":"10.1074\/jbc.M111.248641","article-title":"Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements","volume":"286","author":"Kwakman","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Riool, M., de Breij, A., Kwakman, P.H., Schonkeren-Ravensbergen, E., de Boer, L., Cordfunke, R.A., Malanovic, N., Drijfhout, J.W., Nibbering, P.H., and Zaat, S.A. (2020). Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections. Biochim. Biophys. Acta (BBA)-Biomembr., 1862.","DOI":"10.1016\/j.bbamem.2020.183282"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1006\/bbrc.2001.5884","article-title":"Pseudin-2: An antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog","volume":"288","author":"Soto","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/AAC.01493-18","article-title":"Pse-T2, an antimicrobial peptide with high-level, broad-spectrum antimicrobial potency and skin biocompatibility against multidrug-resistant Pseudomonas aeruginosa infection","volume":"62","author":"Kang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/IDR.S215084","article-title":"Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"12","author":"Swedan","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4274\/tjps.galenos.2020.43078","article-title":"WLBU2 antimicrobial peptide as a potential therapeutic for treatment of resistant bacterial infections","volume":"19","author":"Elsalem","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"26516","DOI":"10.1073\/pnas.1909585117","article-title":"The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection","volume":"116","author":"Mwangi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","article-title":"Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine","volume":"193","author":"Peschel","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1286-4579(01)01494-0","article-title":"Salmonella typhimurium outer membrane remodeling: Role in resistance to host innate immunity","volume":"3","author":"Ernst","year":"2001","journal-title":"Microbes Infect."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/mdr.2017.0392","article-title":"Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria","volume":"24","author":"Moravej","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/1040841X.2012.699025","article-title":"Bacterial resistance to cationic antimicrobial peptides","volume":"39","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/JB.187.15.5387-5396.2005","article-title":"Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis","volume":"187","author":"Tzeng","year":"2005","journal-title":"J. Bacteriol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Joo, H.-S., Fu, C.-I., and Otto, M. (2016). Bacterial strategies of resistance to antimicrobial peptides. Philos. Trans. R. Soc. B Biol. Sci., 371.","DOI":"10.1098\/rstb.2015.0292"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00018-011-0716-4","article-title":"Bacterial resistance mechanisms against host defense peptides","volume":"68","author":"Koprivnjak","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/ph8030366","article-title":"Peptides and Peptidomimetics for Antimicrobial Drug Design","volume":"8","author":"Mojsoska","year":"2015","journal-title":"Pharmaceuticals"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/antibiotics3040461","article-title":"Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria","volume":"3","author":"Nawrocki","year":"2014","journal-title":"Antibiotics"},{"key":"ref_173","first-page":"11","article-title":"Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens","volume":"8","author":"Nizet","year":"2006","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antibiotics4010018","article-title":"Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria","volume":"4","author":"Band","year":"2015","journal-title":"Antibiotics"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/09680519010070011001","article-title":"Bacterial modification of LPS and resistance to antimicrobial peptides","volume":"7","author":"Gunn","year":"2001","journal-title":"J. Endotoxin Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/JB.01313-08","article-title":"Endotoxin, Capsule, and Bacterial Attachment Contribute to Neisseria meningitidis Resistance to the Human Antimicrobial Peptide LL-37","volume":"191","author":"Jones","year":"2009","journal-title":"J. Bacteriol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1099\/mic.0.2008\/022301-0","article-title":"Capsule polysaccharide is a bacterial decoy for antimicrobial peptides","volume":"154","author":"Llobet","year":"2008","journal-title":"Microbiology"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Shafer, W.M. (2006). Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides. Antimicrobial Peptides and Human Disease, Springer.","DOI":"10.1007\/3-540-29916-5"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1002\/psc.3210","article-title":"Bacterial resistance to antimicrobial peptides","volume":"25","author":"Abdi","year":"2019","journal-title":"J. Pept. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1099\/jmm.0.000524","article-title":"In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis","volume":"66","author":"Moravej","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10989-017-9658-5","article-title":"Cytotoxicity and Antibacterial Effect of Trp-Substituted CM11 Cationic Peptide Against Drug-Resistant Isolates of Brucella melitensis Alone and in Combination with Recommended Antibiotics","volume":"25","author":"Moravej","year":"2019","journal-title":"Int. J. PeptMalid. Res. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cis.2017.01.005","article-title":"Delivery systems for antimicrobial peptides","volume":"242","author":"Malmsten","year":"2017","journal-title":"Adv. Colloid. Interface Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcis.2016.05.002","article-title":"Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides","volume":"475","author":"Braun","year":"2016","journal-title":"J. Colloid. Interface Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.2147\/IJN.S180040","article-title":"Reverse micelle-lipid nanocapsules: A novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide","volume":"13","author":"Groo","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2016.02.019","article-title":"Lipid-based nanoformulations for peptide delivery","volume":"502","author":"Matougui","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2217\/nnm-2018-0337","article-title":"A comparison of different strategies for antimicrobial peptides incorporation onto\/into lipid nanocapsules","volume":"14","author":"Matougui","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcis.2019.07.028","article-title":"Degradable dendritic nanogels as carriers for antimicrobial peptides","volume":"554","author":"Singh","year":"2019","journal-title":"J. Colloid. Interface Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.2147\/IJN.S139625","article-title":"Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus","volume":"12","author":"Umerska","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2016.04.028","article-title":"Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules","volume":"506","author":"Umerska","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Johnson, K., Delaney, J.C., Guillard, T., Reffuveille, F., Varin-Simon, J., Li, K., Wollacott, A., Frapy, E., Mong, S., and Tissire, H. (2023). Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011612"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Kim, G.C., Cheon, D.H., and Lee, Y. (2021). Challenge to overcome current limitations of cell-penetrating peptides. Biochim. Biophys. Acta Proteins Proteom., 1869.","DOI":"10.1016\/j.bbapap.2021.140604"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s11095-014-1550-9","article-title":"Cell-penetrating antimicrobial peptides\u2014Prospectives for targeting intracellular infections","volume":"32","author":"Bahnsen","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1021\/acsomega.9b02278","article-title":"Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity","volume":"4","author":"Lee","year":"2019","journal-title":"ACS Omega"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Mathur, H., Field, D., Rea, M.C., Cotter, P.D., Hill, C., and Ross, R.P. (2017). Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01205"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2174\/1568026619666181129141524","article-title":"Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens","volume":"18","author":"David","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.peptides.2009.06.004","article-title":"In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1\u201318) in combination with conventional antibiotics against Stenotrophomonas maltophilia","volume":"30","author":"Maisetta","year":"2009","journal-title":"Peptides"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Le\u00f3n-Buitimea, A., Garza-C\u00e1rdenas, C.R., Garza-Cervantes, J.A., Lerma-Escalera, J.A., and Morones-Ram\u00edrez, J.R. (2020). The demand for new antibiotics: Antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01669"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/med.21879","article-title":"Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections","volume":"42","author":"Zhu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsinfecdis.0c00016","article-title":"Combined Efficacy of an Antimicrobial Cationic Peptide Polymer with Conventional Antibiotics to Combat Multidrug-Resistant Pathogens","volume":"6","author":"Thappeta","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1517\/13543776.10.10.1583","article-title":"Non-ribosomal peptide antibiotics","volume":"10","author":"Mankelow","year":"2000","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014The need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jgar.2020.02.001","article-title":"Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model","volume":"22","author":"Mermer","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1742-1241.2007.01318.x","article-title":"Dalbavancin: A novel antimicrobial","volume":"61","author":"Chen","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11534440-000000000-00000","article-title":"New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin","volume":"70","author":"Zhanel","year":"2010","journal-title":"Drugs"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1128\/AAC.00194-12","article-title":"In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus","volume":"56","author":"Saravolatz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1021\/acs.biochem.8b00818","article-title":"Comparison of the Effects of Daptomycin on Bacterial and Model Membranes","volume":"57","author":"Lee","year":"2018","journal-title":"Biochemistry"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","article-title":"Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens","volume":"38","author":"Carpenter","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.procbio.2017.02.006","article-title":"Research advances on plectasin and its derivatives as new potential antimicrobial candidates","volume":"56","author":"Li","year":"2017","journal-title":"Process Biochem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nbt1288","article-title":"An anti-infective peptide that selectively modulates the innate immune response","volume":"25","author":"Scott","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0196-9781(98)00055-2","article-title":"Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients","volume":"19","author":"Catania","year":"1998","journal-title":"Peptides"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm0204338","article-title":"Novel alpha-melanocyte stimulating hormone peptide analogues with high candidacidal activity","volume":"46","author":"Grieco","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14656566.7.6.653","article-title":"Antimicrobial peptides: Therapeutic potential","volume":"7","author":"Zhang","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/IAI.69.3.1469-1476.2001","article-title":"Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria","volume":"69","author":"Nibbering","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AAC.47.1.262-267.2003","article-title":"Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species","volume":"47","author":"Lupetti","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.49.6.2438-2444.2005","article-title":"Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model","volume":"49","author":"Faber","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12275-021-0649-z","article-title":"Rediscovery of antimicrobial peptides as therapeutic agents","volume":"59","author":"Ryu","year":"2021","journal-title":"J. Microbiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1021\/ic902547t","article-title":"Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5","volume":"49","author":"Porciatti","year":"2010","journal-title":"Inorg. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/cts.12792","article-title":"Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial","volume":"13","author":"Hogendoorn","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.TA.0000047047.79701.6D","article-title":"Treatment of infected wounds with the antimicrobial peptide D2A21","volume":"54","author":"Chalekson","year":"2003","journal-title":"J. Trauma."},{"key":"ref_221","unstructured":"Giuliani, A., and Rinaldi, A.C. (2010). Therapeutic Potential of HDPs as Immunomodulatory Agents. Antimicrobial Peptides: Methods and Protocols, Humana Press."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1073\/pnas.0606088103","article-title":"Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic","volume":"103","author":"McClerren","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1128\/AEM.00730-09","article-title":"Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins","volume":"75","author":"Begley","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.cell.2017.12.009","article-title":"Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries","volume":"172","author":"Tucker","year":"2018","journal-title":"Cell"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12275-020-9563-z","article-title":"User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation","volume":"58","author":"Shaker","year":"2020","journal-title":"J. Microbiol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Chen, C.H., and Lu, T.K. (2020). Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010024"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.colsurfb.2017.02.003","article-title":"Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity","volume":"153","author":"Maturana","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: Science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"115377","DOI":"10.1016\/j.ejmech.2023.115377","article-title":"Antimicrobial peptides: Structure, mechanism, and modification","volume":"255","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:35:50Z","timestamp":1760114150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":231,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ph17111555"],"URL":"https:\/\/doi.org\/10.3390\/ph17111555","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}